Back to Deutsche Bank AG Deutsche Bank AG

VKTXVKTX

Showing 8 of 31 quarters

Position history for Deutsche Bank AGDeutsche Bank AG's holdings in Viking Therapeutics, Inc.

Yes. Deutsche Bank holds 23,695 shares of VKTX (Viking Therapeutics), worth $924,342, as of its Q2 2026 13F filing. It increased the position by 14,994 shares (+172.3%) from Q1 2026. Deutsche Bank has held VKTX in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$924,342

Current Shares

23,695

Total Value Change

-$450,182

Total Shares Change

+1,984

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
23,695
+172.3%
$924,3420.0%$39.01
40
2026-Q1
Increased
8,701
+9.1%
$283,1300.0%$32.54
25
2025-Q4
Decreased
7,979
-8.4%
$280,7010.0%$35.18
0
2025-Q3
Increased
8,712
+18.4%
$228,9520.0%$26.28
27
2025-Q2
Increased
7,358
+6.5%
$194,9870.0%$26.50
24
2025-Q1
Increased
6,911
+7.5%
$166,9000.0%$24.15
24
2024-Q4
Decreased
6,427
-70.4%
$258,6220.0%$40.24
0
2024-Q3
Decreased
21,711
-82.6%
$1.4M0.0%$63.31
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used